Publication | Closed Access
A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)
47
Citations
20
References
2024
Year
MedicineMetronomic TherapyPathologyGlobal Phase 3Bronchial NeoplasmFirst-line TreatmentCancer TreatmentOncologyRadiation OncologyLung Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1